No Data
No Data
Aerovate(AVTE.US) Officer Sells US$96,119.34 in Common Stock
$Aerovate(AVTE.US)$ Officer Dake Benjamin T sold 3,432 shares of Common Stock on Mar 25, 2024 at an average price of $28.0068 for a total value of $96,119.34.Source: Announcement What is statement of
Aerovate Therapeutics Announces Upcoming Investor Presentation Access
Aerovate Therapeutics to Present Patient Baseline Characteristics of the Phase 2b Portion of the Phase 2b/Phase 3 IMPAHCT Trial at the American Thoracic Society 2024 International Conference
WALTHAM, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Aerovate Therapeutics, Inc. (NASDAQ:AVTE), a clinical stage biopharmaceutical company focused on developing drugs that improve the lives of patients with rare
Analysts Offer Insights on Healthcare Companies: Healthequity (HQY), Aerovate Therapeutics (AVTE) and Delcath Systems (DCTH)
Aerovate Therapeutics Inc (AVTE) Reports Increased R&D Expenses and Net Loss in 2023
Aerovate Therapeutics: A Strong Buy Ahead of Key Clinical Data Release
No Data
mm__et : How to subscribe to IPO?
Fred3911 mm__et: How to subscribe?
TanJJ12629 :
SSSTW Fred3911: Only US moo moo account can subscribe
102735796me : Ok
View more comments...